Giovanni Asole
@asoleee.bsky.social
Reposted by Giovanni Asole
No endless waiting ⏳
No invasive procedures 💉
Just fast, accurate, and early answers ⚡
Our goal: detect cancer early through a simple blood test — powered by RNA🩸🧬
Behind every breakthrough is a dedicated team 🧬💻🧪
#LiquidBiopsy #RNA #CancerDetection #Bioinformatics #PrecisionMedicine #TeamScience
No invasive procedures 💉
Just fast, accurate, and early answers ⚡
Our goal: detect cancer early through a simple blood test — powered by RNA🩸🧬
Behind every breakthrough is a dedicated team 🧬💻🧪
#LiquidBiopsy #RNA #CancerDetection #Bioinformatics #PrecisionMedicine #TeamScience
July 22, 2025 at 9:27 AM
No endless waiting ⏳
No invasive procedures 💉
Just fast, accurate, and early answers ⚡
Our goal: detect cancer early through a simple blood test — powered by RNA🩸🧬
Behind every breakthrough is a dedicated team 🧬💻🧪
#LiquidBiopsy #RNA #CancerDetection #Bioinformatics #PrecisionMedicine #TeamScience
No invasive procedures 💉
Just fast, accurate, and early answers ⚡
Our goal: detect cancer early through a simple blood test — powered by RNA🩸🧬
Behind every breakthrough is a dedicated team 🧬💻🧪
#LiquidBiopsy #RNA #CancerDetection #Bioinformatics #PrecisionMedicine #TeamScience
Reposted by Giovanni Asole
Fresh insights from the Flomics team! 🧬💻
Our new preprint is out:
“Systematic cross-study assessment of RNA-Seq workflows for plasma cfRNA profiling”
Is cfRNA the wild west of protocols? We investigated.
📄 Read it: www.biorxiv.org/cgi/content/...
Our new preprint is out:
“Systematic cross-study assessment of RNA-Seq workflows for plasma cfRNA profiling”
Is cfRNA the wild west of protocols? We investigated.
📄 Read it: www.biorxiv.org/cgi/content/...
Systematic cross-study assessment of RNA-Seq experimental workflows for plasma cell-free transcriptome profiling
Plasma cell-free RNA (cfRNA) is a promising source of non-invasive biomarkers, but its clinical translation is hindered by technical challenges and a lack of protocol standardization, which compromise...
www.biorxiv.org
July 15, 2025 at 8:39 AM
Fresh insights from the Flomics team! 🧬💻
Our new preprint is out:
“Systematic cross-study assessment of RNA-Seq workflows for plasma cfRNA profiling”
Is cfRNA the wild west of protocols? We investigated.
📄 Read it: www.biorxiv.org/cgi/content/...
Our new preprint is out:
“Systematic cross-study assessment of RNA-Seq workflows for plasma cfRNA profiling”
Is cfRNA the wild west of protocols? We investigated.
📄 Read it: www.biorxiv.org/cgi/content/...
Reposted by Giovanni Asole
👋 Hi Bluesky! We’re Flomics, a biotech company focused on liquid biopsy & transcriptomics.
Passionate about robust science, reproducibility & biomarker discovery.
Excited to join the community — stay tuned for our first big announcement! 🚀
#LiquidBiopsy #Genomics #OpenScience
Passionate about robust science, reproducibility & biomarker discovery.
Excited to join the community — stay tuned for our first big announcement! 🚀
#LiquidBiopsy #Genomics #OpenScience
July 9, 2025 at 3:16 PM
👋 Hi Bluesky! We’re Flomics, a biotech company focused on liquid biopsy & transcriptomics.
Passionate about robust science, reproducibility & biomarker discovery.
Excited to join the community — stay tuned for our first big announcement! 🚀
#LiquidBiopsy #Genomics #OpenScience
Passionate about robust science, reproducibility & biomarker discovery.
Excited to join the community — stay tuned for our first big announcement! 🚀
#LiquidBiopsy #Genomics #OpenScience